Literature DB >> 27510828

Next-Generation Sequencing: a Diagnostic One-Stop Shop for Hepatitis C?

Mario Poljak1.   

Abstract

Before starting chronic hepatitis C treatment, the viral genotype/subtype has to be accurately determined and potentially coupled with drug resistance testing. Due to the high genetic variability of the hepatitis C virus, this can be a demanding task that can potentially be streamlined by viral whole-genome sequencing using next-generation sequencing as demonstrated by an article in this issue of the Journal of Clinical Microbiology by E. Thomson, C. L. C. Ip, A. Badhan, M. T. Christiansen, W. Adamson, et al. (J Clin Microbiol. 54:2455-2469, 2016, http://dx.doi.org/10.1128/JCM.00330-16).
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27510828      PMCID: PMC5035410          DOI: 10.1128/JCM.01423-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C Virus.

Authors:  Charlotte Hedskog; Krishna Chodavarapu; Karin S Ku; Simin Xu; Ross Martin; Michael D Miller; Hongmei Mo; Evguenia Svarovskaia
Journal:  J Clin Microbiol       Date:  2015-04-15       Impact factor: 5.948

2.  High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.

Authors:  Marine Karchava; Jesper Waldenström; Monica Parker; Renee Hallack; Lali Sharvadze; Lana Gatserelia; Nikoloz Chkhartishvili; Natia Dvali; Lela Dzigua; Ekaterine Dolmazashvili; Helene Norder; Tengiz Tsertsvadze
Journal:  Hepatol Res       Date:  2015-03-24       Impact factor: 4.288

3.  Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains.

Authors:  P Trémeaux; A Caporossi; C Ramière; E Santoni; N Tarbouriech; M-A Thélu; K Fusillier; L Geneletti; O François; V Leroy; W P Burmeister; P André; P Morand; S Larrat
Journal:  Clin Microbiol Infect       Date:  2016-01-28       Impact factor: 8.067

Review 4.  Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens.

Authors:  Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2016-04-11       Impact factor: 22.682

Review 5.  Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights.

Authors:  Matthias Götte; Jordan J Feld
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-05-05       Impact factor: 46.802

6.  High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods.

Authors:  Josep Quer; Josep Gregori; Francisco Rodríguez-Frias; Maria Buti; Antonio Madejon; Sofia Perez-del-Pulgar; Damir Garcia-Cehic; Rosario Casillas; Maria Blasi; Maria Homs; David Tabernero; Miguel Alvarez-Tejado; Jose Manuel Muñoz; Maria Cubero; Andrea Caballero; Jose Antonio del Campo; Esteban Domingo; Irene Belmonte; Leonardo Nieto; Sabela Lens; Paloma Muñoz-de-Rueda; Paloma Sanz-Cameno; Silvia Sauleda; Marta Bes; Jordi Gomez; Carlos Briones; Celia Perales; Julie Sheldon; Lluis Castells; Lluis Viladomiu; Javier Salmeron; Angela Ruiz-Extremera; Rosa Quiles-Pérez; Ricardo Moreno-Otero; Rosario López-Rodríguez; Helena Allende; Manuel Romero-Gómez; Jaume Guardia; Rafael Esteban; Javier Garcia-Samaniego; Xavier Forns; Juan Ignacio Esteban
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

7.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

8.  Mixed genotype hepatitis C infections and implications for treatment.

Authors:  Anna L McNaughton; Emma C Thomson; Kate Templeton; Rory N Gunson; E Carol McWilliam Leitch
Journal:  Hepatology       Date:  2014-01-13       Impact factor: 17.425

9.  Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice.

Authors:  Victoria González; Meissiner Gomes-Fernandes; Elisabet Bascuñana; Sònia Casanovas; Verónica Saludes; Elena Jordana-Lluch; Lurdes Matas; Vicenç Ausina; Elisa Martró
Journal:  J Clin Virol       Date:  2013-06-02       Impact factor: 3.168

10.  Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.

Authors:  Natalia Chueca; Isidro Rivadulla; Rubén Lovatti; Gabriel Reina; Ana Blanco; Jose Angel Fernandez-Caballero; Laura Cardeñoso; Javier Rodriguez-Granjer; Miriam Fernandez-Alonso; Antonio Aguilera; Marta Alvarez; Juan Carlos Galán; Federico García
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more
  2 in total

1.  Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.

Authors:  María Eugenia Soria; Josep Gregori; Qian Chen; Damir García-Cehic; Meritxell Llorens; Ana I de Ávila; Nathan M Beach; Esteban Domingo; Francisco Rodríguez-Frías; María Buti; Rafael Esteban; Juan Ignacio Esteban; Josep Quer; Celia Perales
Journal:  BMC Infect Dis       Date:  2018-09-03       Impact factor: 3.090

2.  The First Complete Genome Sequences of Hepatitis C Virus Subtype 2b from Latin America: Molecular Characterization and Phylogeographic Analysis.

Authors:  Natália Spitz; José J Barros; Kycia M do Ó; Carlos E Brandão-Mello; Natalia M Araujo
Journal:  Viruses       Date:  2019-10-31       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.